Effects of Vasopressin on Blood Flow in Liver Metastases
Author Information
Author(s): S.A. Jenkins, D.W. Day, B. Mooney, P. Devitt, I. Taylor, R. Shields
Primary Institution: University Departments of Surgery & Pathology, Royal Liverpool Hospital
Hypothesis
The study investigates how different rates of vasopressin infusion and hepatic artery ligation affect blood flow to normal and metastatic liver tissue.
Conclusion
Vasopressin infusion can either increase or decrease blood flow to liver tissue depending on the infusion rate, which may have implications for treating liver metastases.
Supporting Evidence
- Low rates of vasopressin infusion decreased portal venous flow but increased blood flow to liver tissue.
- High rates of vasopressin infusion reversed these effects.
- Hepatic artery ligation abolished the increase in blood flow to liver tissue following vasopressin infusion.
Takeaway
This study shows that giving vasopressin can change how much blood flows to the liver, which might help doctors treat liver cancer better.
Methodology
The study involved 36 male Wistar rats, measuring blood flow using vasopressin infusion and hepatic artery ligation.
Limitations
The study was conducted on rats, which may not fully represent human physiology.
Participant Demographics
36 male Wistar rats
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website